---
title: "Diagnostic and staging evaluation of multiple myeloma"
slug: "diagnostic-and-staging-evaluation-of-multiple-myeloma"
date: "2023-05-26"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[clinical manifestations of multiple myeloma (MM)]]

# Diagnostic and staging evaluation of multiple myeloma

> BM plasma cells â‰¥10% or bx-proven plasmacytoma

## & â‰¥1 MM-defining event

- myeloma-related organ or tissue impairment (ROTI) = lytic bone lesions, Ca >11 mg/dL, Cr >2 mg/dL, or Hb <10 g/dL

- any of the following biomarkers: BM plasma cells â‰¥60%, serum free light chain (FLC) ratio â‰¥100:1, >1 focal lesion on MRI

## Variants

1. Solitary bone or **[[extramedullary plasmacytoma]]**: no periph plasmacytosis or other ROTI
2. Plasma cell leukemia: plasma cell count **>2000/ÂµL in peripheral blood**
3. Nonsecretory MM (~2% of MM Pts; MM **without M protein**)

- âœ“ Peripheral smear for **rouleaux** ,
- Ca, alb, Cr; â†“ anion gap, â†‘ globulin, â†‘ ESR
- [[protein electrophoresis and immunofixation]]
- Î²2-microglobulin (Î²2M) and **LDH levels** reflect tumor burden

## BM bx cytogenetics

- normal karyotype better than abnl.
- Standard risk ðŸŸ¢
  = [[hyperdiploidy]] or **t(11;14)**;
- high risk ðŸ”´
  = hypodiploidy, **del. 17p13** (~10% of Pts), **t(4;14)** & **t(4;16).**

---

- Skeletal survey (plain X-rays)
  : to identify lytic bone lesions and areas at â†£ risk for pathologic fracture.
- Whole-body PET-CT (scalp to toe) or MRI often used to detect bone lesions.

---

![ðŸ¦€](https://i.imgur.com/uiOrDBl.png)
